Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun 21;16(23):2835-40.
doi: 10.3748/wjg.v16.i23.2835.

Plexiform angiomyxoid myofibroblastic tumor of the stomach

Affiliations
Review

Plexiform angiomyxoid myofibroblastic tumor of the stomach

Yoshihisa Takahashi et al. World J Gastroenterol. .

Abstract

Plexiform angiomyxoid myofibroblastic tumor of the stomach is a unique mesenchymal tumor that we first described in 2007. The tumor is very rare, and to date, only 18 cases confirmed by immunohistochemistry have been reported in the literature. The patients' ages ranged from 7 to 75 years (mean, 43 years), and the male-to-female ratio was approximately 1:1. Representative clinical symptoms are ulceration, associated upper gastrointestinal bleeding (hematemesis), and anemia. The tumors are located at the antrum in all cases, and grossly, the tumor is whitish to brownish or reddish, and forms a lobulated submucosal or transmural mass. Microscopically, the tumor is characterized by a plexiform growth pattern, the proliferation of cytologically bland spindle cells, and a myxoid stroma that is rich in small vessels and positive for Alcian blue stain. Immunohistochemically, the tumor cells are positive for alpha-smooth muscle actin and negative for KIT and CD34. Differential diagnoses include gastrointestinal stromal tumor and other mesenchymal tumors of the gastrointestinal tract. Some authors proposed that this tumor should be designated as "plexiform fibromyxoma", but this designation might cause confusion. The tumor is probably benign and thus far, neither recurrence nor metastasis has been reported.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Gross appearance of a case of plexiform angiomyxoid myofibroblastic tumor (PAMT). A: A reddish and lobulated tumor protrudes from the serosa; B: The cut section of the tumor. The tumor causes ulceration and perforation.
Figure 2
Figure 2
Histological appearance of PAMT. A: The tumor shows a multinodular plexiform growth pattern (HE stain, × 20); B: Spindle-shaped bland tumor cells are separated by an abundant intercellular myxoid matrix. The stroma is rich in small vessels (HE stain, × 100); C: Tumor cells possess oval nuclei and a slightly eosinophilic cytoplasm. The nucleoli are inconspicuous and the cell borders are indistinct (HE stain, × 200); D: The stroma is positive for Alcian blue stain (× 200); E: Stromal collagenization is occasionally observed (HE stain, × 200).
Figure 3
Figure 3
The results of immunohistochemical staining. A: The tumor cells are negative for KIT. The scattered KIT-positive cells are mast cells (× 200); B: The tumor cells are diffusely positive for smooth muscle actin (× 200).

References

    1. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577–580. - PubMed
    1. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152:1259–1269. - PMC - PubMed
    1. Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, Hibbard MK, Chen CJ, Xiao S, Tuveson DA, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 2001;61:8118–8121. - PubMed
    1. Sakurai S, Fukasawa T, Chong JM, Tanaka A, Fukayama M. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. Am J Pathol. 1999;154:23–28. - PMC - PubMed
    1. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998;11:728–734. - PubMed